Mode
Text Size
Log in / Sign up
N/A N=24 Randomized Supportive Care

SMS System for Patients With Uncontrolled Hypertension

Hypertension

Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Number of Participants Screened — 12; 12 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SMS System (Other); blood pressure control education (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Wake Forest University Health Sciences
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Screened
12; 12
PRIMARY
Number of Subjects Enrolled
12; 12
PRIMARY
Number of Subjects Who Refuse Participation
0; 0
PRIMARY
Number of Subjects Excluded Without SMS Capability
0; 0
PRIMARY
Proportion of Participants Continuing myHealth
0; 0
PRIMARY
Number of Participants Who Responded to SMS With At Least One Home BP Measurement
8
PRIMARY
SMS Participation
12
PRIMARY
System Usability Scale (SUS)
92.25
SECONDARY
Medication Adherence
SECONDARY
Medication Adherence Questionnaire
2.17; 2.02; 0.93; 1.8
SECONDARY
Monitoring of SBP
15; 13
SECONDARY
Monitoring of DBP
10; 8
SECONDARY
Initial and Follow up BP in Office
10; 10; 10; 10
SECONDARY
Number of Participants Considered No-Shows at Clinic Visits
1; 1
SECONDARY
Coordinator Time

Summary

This is a pilot study to determine the potential of utilizing Short Message Service (SMS) messaging to improve health outcomes for patients with uncontrolled hypertension receiving care from the Outpatient Internal Medicine Clinic at Wake Forest Baptist Hospital.

Eligibility Criteria

Inclusion Criteria

  • Patients who have been diagnosed with hypertension
  • 18 and older
  • stage 2 hypertension or greater systolic blood pressure [(SBP)>140 and diastolic blood pressure (DBP) >90] who are receiving antihypertensive treatment.

Exclusion Criteria

  • Pregnancy
  • end-stage renal disease (on hemodialysis or peritoneal dialysis)
  • hospice or nursing home care
  • dementia
  • Patients who do not have a phone with Short Message Service (SMS) capabilities will also be excluded.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03596242). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search